AllAnalyst Report
logoMorningstarSeptember 18, 2024

Cencora, Inc.: Cencora Earnings: Strong Sales Growth Returns as GLP-1s Constraint Relaxes but Margin Sags

Symbols
COR
Sector(s)
Healthcare
Rating
Current Price
$221.07
Fair Value
Economic Moat
Stewardship
Summary

Cencora is one of three domestic leading pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health constitute over 90% of the US pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health

Upgrade to begin using premium research reports and get so much more.

Exclusive reports, detailed company profiles, and best-in-class trade insights to take your portfolio to the next level
Upgrade